Wellstat Therapeutics Corporation - Product Pipeline Review - 2012 New Report


Naperville, IL -- (SBWire) -- 09/26/2012 --Wellstat Therapeutics Corporation - Product Pipeline Review - 2012 provides data on the Wellstat Therapeutics Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- Wellstat Therapeutics Corporation - Brief Wellstat Therapeutics Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Wellstat Therapeutics Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Wellstat Therapeutics Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Wellstat Therapeutics Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Wellstat Therapeutics Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Wellstat Therapeutics Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Wellstat Therapeutics Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Wellstat Therapeutics Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Wellstat Therapeutics Corporation and identify potential opportunities in those areas.


Current R&D Portfolio of Wellstat Therapeutics Corporation; Wellstat Therapeutics Corporation - Key Therapeutics; Wellstat Therapeutics Corporation - Pipeline Overview and Promising Molecules; Wellstat Therapeutics Corporation - News; Wellstat Therapeutics Corporation - Latest Updates; Wellstat Therapeutics Corporation - Pipeline; Wellstat Therapeutics Corporation - Discontinued/Dormant Projects

To view table of contents for this market report please visit:

Media Relations Contact

Web Master

View this press release online at: http://rwire.com/167603